[go: up one dir, main page]

MX9605986A - Analogos sinteticos de peptidos de la proteina de la superficie pulmonar sp-c. - Google Patents

Analogos sinteticos de peptidos de la proteina de la superficie pulmonar sp-c.

Info

Publication number
MX9605986A
MX9605986A MX9605986A MX9605986A MX9605986A MX 9605986 A MX9605986 A MX 9605986A MX 9605986 A MX9605986 A MX 9605986A MX 9605986 A MX9605986 A MX 9605986A MX 9605986 A MX9605986 A MX 9605986A
Authority
MX
Mexico
Prior art keywords
synthetic peptide
peptide analogs
surfactant protein
lung surfactant
formula
Prior art date
Application number
MX9605986A
Other languages
English (en)
Other versions
MXPA96005986A (es
Inventor
Klaus P Schafer
Klaus Melchers
Rudiger Nave
Wolf-Rudiger Ulrich
Ernst Sturm
Uwe Kruger
Dietrich Hafner
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6519392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9605986(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of MX9605986A publication Critical patent/MX9605986A/es
Publication of MXPA96005986A publication Critical patent/MXPA96005986A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La descripcion se refiere a polipéptidos novedosos de formula (I) con propiedades de actividad pulmonar. Dichos polipéptidos pueden producirse en grandes cantidades y en forma de alta pureza y son tan efectivos como surfactantes pulmonares naturales. Pueden emplearse en la elaboracion de compuestos farmacéuticos para el tratamiento del síndrome de Falla Respiratoria en bebés prematuros y adultos. En dicha formula (I): A representa H o Phe, B representa Phe o Trp, y C representa Ile, Leu o Ser.
MXPA/A/1996/005986A 1994-05-31 1996-11-29 Analogos sinteticos de peptidos de la proteina de la superficie pulmonar sp-c MXPA96005986A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4418936.2 1994-05-31
DE4418936A DE4418936A1 (de) 1994-05-31 1994-05-31 Polypeptid

Publications (2)

Publication Number Publication Date
MX9605986A true MX9605986A (es) 1998-06-30
MXPA96005986A MXPA96005986A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
CN1130374C (zh) 2003-12-10
DK0764172T3 (da) 2005-01-10
CA2191344A1 (en) 1995-12-07
KR970703367A (ko) 1997-07-03
EP0764172B1 (de) 2004-09-01
CZ350296A3 (en) 1997-05-14
ATE275154T1 (de) 2004-09-15
CZ286976B6 (en) 2000-08-16
NZ287447A (en) 1998-01-26
HK1000891A1 (en) 2004-09-17
SK282441B6 (sk) 2002-02-05
PT764172E (pt) 2005-01-31
ES2227548T3 (es) 2005-04-01
UA35636C2 (uk) 2001-04-16
PL181234B1 (pl) 2001-06-29
HU9603249D0 (en) 1997-01-28
SK152496A3 (en) 1997-06-04
DE59510941D1 (de) 2004-10-07
HUT76952A (hu) 1998-01-28
FI964766A7 (fi) 1996-11-29
NO965052L (no) 1997-01-28
NO965052D0 (no) 1996-11-27
CN1154117A (zh) 1997-07-09
SI0764172T1 (en) 2005-02-28
RU2145611C1 (ru) 2000-02-20
WO1995032992A1 (de) 1995-12-07
HU220191B (hu) 2001-11-28
FI118126B (fi) 2007-07-13
KR100355626B1 (ko) 2002-12-26
NO317149B1 (no) 2004-08-30
AU2616995A (en) 1995-12-21
CY2552B1 (en) 2008-07-02
JP3359638B2 (ja) 2002-12-24
JPH10504025A (ja) 1998-04-14
EP0764172A1 (de) 1997-03-26
BG63210B1 (bg) 2001-06-29
FI964766A0 (fi) 1996-11-29
BR9507811A (pt) 1997-09-16
BR9507811B1 (pt) 2009-05-05
DE4418936A1 (de) 1996-02-08
AU690280B2 (en) 1998-04-23
RO118752B1 (ro) 2003-10-30
BG101028A (en) 1998-01-30
EE9600175A (et) 1997-06-16
EE03775B1 (et) 2002-06-17
PL317420A1 (en) 1997-04-14
CA2191344C (en) 2003-04-08
US5874406A (en) 1999-02-23

Similar Documents

Publication Publication Date Title
CA2191344A1 (en) Synthetic peptide analogs of lung surfactant protein sp-c
SE8007763L (sv) Sett att framstella en polypeptid
ES2150916T3 (es) Utilizacion del acido gentisico o del alcohol gentisilico para estabilizar peptidos y proteinas radiomarcados.
DK413986D0 (da) Syntetisk peptid og farmaceutisk middel indeholdende peptidet
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
FI904074A7 (fi) Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
IL72018A (en) Biologically active heptapeptides structurally related to region within growth hormones and pharmaceutical compositions comprising them
ATE6251T1 (de) Acylpeptide und pharmazeutische praeparate davon, sowie deren herstellung und verwendung.
ES2092539T3 (es) Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
SE8802569L (sv) Foerbaettringar vid eller avseende somatosstatiner
ES2112255T3 (es) Complejos proteicos que tienen actividad del factor viii:c y su produccion.
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
ATE110742T1 (de) Peptid-verbindungen.
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
ES2149177T3 (es) Composiciones para el tratamiento del sindrome de fatiga cronica.
EP0542934B1 (en) Use of somatostatin analogues for treating melanomas
AR241800A1 (es) Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo.
JPS649938A (en) Oral ingestive composition
Hruby et al. Synthesis and some pharmacological properties of tocinoic acid and deaminotocinoic acid
ATE92078T1 (de) Pharmakologisch aktive peptide.
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
AR029930A1 (es) Peptidos analogos de la sustancia p, procesos de sintesis de los mismos, composiciones y el uso de dichos peptidos para la manufactura de un medicamento para el tratamiento de cancer
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
HC Change of company name or juridical status
HC Change of company name or juridical status
FG Grant or registration
HC Change of company name or juridical status